NDC 68084-112-11
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68084-112
- Requested NDC
- 68084-112-11
- Package NDCs from labels
- 68084-112-11
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68084-112-01 | EA - Each | 68084-112 | be17f831-c22e-452a-88b4-71f3a954a1a9 | 1 | 2012-07-24 |
| 68084-112-11 | EA - Each | 68084-112 | 91eaf166-7d59-4e05-9ea0-a32ef6f163bb | 1 | 2012-07-24 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ondansetron | ONDANSETRON | American Health Packaging | 92b96072-e8f2-4fd6-aaa0-b73fed214319 | 2026-06-01 | Warnings, Adverse reactions | American Health Packaging |
| Lithium Carbonate | LITHIUM CARBONATE | American Health Packaging | 049902a9-3af1-4863-994e-15f36e7a9793 | 2026-05-26 | Boxed warning, Warnings, Adverse reactions | American Health Packaging |
| Lorazepam | LORAZEPAM | American Health Packaging | 6dfbe8be-168c-44e9-acfa-fa838b92d3b7 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | American Health Packaging |
| Quetiapine fumarate | QUETIAPINE | American Health Packaging | 9f927ae2-a0ae-4953-99ba-8de59ee5bfca | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | American Health Packaging |
| prednisone | PREDNISONE | American Health Packaging | fdcd49a6-6cb1-49f8-9f4c-feb475c129b3 | 2026-05-21 | Warnings, Adverse reactions | American Health Packaging |
| Glipizide | GLIPIZIDE | Bryant Ranch Prepack | 9b405ff3-6ce5-460a-9406-db92e0e6ab1b | 2026-05-21 | Warnings, Adverse reactions | Glipizide GLIPIZIDE |
| Albuterol Sulfate | ALBUTEROL SULFATE | American Health Packaging | b0a5da99-6553-4088-ae27-7fa194438340 | 2026-05-20 | Warnings, Adverse reactions | American Health Packaging |
| Sotalol Hydrochloride | SOTALOL HYDROCHLORIDE | American Health Packaging | 4614480b-b36e-4dbd-9fc0-d083890d297d | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | American Health Packaging |
| Budesonide | BUDESONIDE | American Health Packaging | c7df2a10-4166-423e-bb60-5f3a8234f26c | 2026-05-18 | Warnings, Adverse reactions | American Health Packaging |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | 69a21bd3-3364-4035-b098-3808cc8cf8b2 | 2026-05-17 | Warnings, Adverse reactions | Glipizide GLIPIZIDE |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | c582d7d0-4db0-4296-8131-baefd1a671b2 | 2026-05-17 | Warnings, Adverse reactions | Glipizide GLIPIZIDE |
| Glipizide | GLIPIZIDE | Coupler LLC | 51b35391-7672-c02f-e063-6294a90af54e | 2026-05-13 | Warnings, Adverse reactions | Glipizide GLIPIZIDE |
| Paroxetine | PAROXETINE | American Health Packaging | b5a8f864-a53d-48d9-aca6-6b64017fb168 | 2026-05-13 | Boxed warning, Warnings, Adverse reactions | American Health Packaging |
| Glipizide | GLIPIZIDE | Bryant Ranch Prepack | 2aa01a7e-a703-426f-9cd3-70b88d0a8e7f | 2026-05-13 | Warnings, Adverse reactions | Glipizide GLIPIZIDE |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | American Health Packaging | fab97112-e276-40e0-bc82-0a29d7fa75fa | 2026-05-12 | Boxed warning, Warnings, Adverse reactions | American Health Packaging |
| Glipizide | GLIPIZIDE | Cardinal Health 107, LLC | bf1f5a5d-79b0-4fc5-96f2-bd5119b56e2a | 2026-05-08 | Warnings, Adverse reactions | Glipizide GLIPIZIDE |
| Glipizide | GLIPIZIDE | Preferred Pharmaceuticals Inc.. | 02857195-33e9-4c1f-9e5f-7cc62f283649 | 2026-05-07 | Warnings, Adverse reactions | Glipizide GLIPIZIDE |
| Glipizide | GLIPIZIDE | Preferred Pharmaceuticals Inc. | 548c1f50-dbf0-49cc-b58b-fcc5937affa8 | 2026-05-07 | Warnings, Adverse reactions | Glipizide GLIPIZIDE |
| Glipizide | GLIPIZIDE | Preferred Pharmaceuticals Inc. | 4632b4ec-d2f1-40cc-8ef4-256413d8dbec | 2026-05-06 | Warnings, Adverse reactions | Glipizide GLIPIZIDE |
| Glipizide | GLIPIZIDE | Preferred Pharmaceuticals, Inc. | 097424ef-612f-4bc2-809a-e5bb8eeae244 | 2026-05-06 | Warnings, Adverse reactions | Glipizide GLIPIZIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.